Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery

NCT ID: NCT07273136

Last Updated: 2025-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-10

Study Completion Date

2026-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the safety and efficacy of combined subcostal and lateral transversus abdominis plane (TAP) for postoperative analgesia versus thoracic epidural anesthesia (TEA) in patients undergoing major abdominal cancer surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative pain is treated using a variety of techniques. It is possible to deliver opioids intravenously, neuraxially, or both.

Thoracic epidural anesthesia (TEA) has long been considered the benchmark for analgesia in major abdominal operations due to its consistent efficacy in pain control and additional benefits such as reduced ileus and improved pulmonary function.

Transversus abdominis plane (TAP) blocks can be a critical component of postoperative pain management, and they play a crucial role in Enhanced Recovery After Surgery (ERAS) protocols, as they significantly affect recovery and patient well-being.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subcostal Lateral Transversus Abdominis Plane Block Postoperative Analgesia Thoracic Epidural Analgesia Major Abdominal Cancer Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subcostal and lateral transversus abdominis plane block group

Patients will receive an ultrasound-guided combined subcostal and lateral transversus abdominis plane block.

Group Type EXPERIMENTAL

Subcostal and lateral transversus abdominis plane block

Intervention Type OTHER

Patients will receive an ultrasound-guided combined subcostal and lateral transversus abdominis plane block.

Thoracic epidural anesthesia group

Patients will receive an ultrasound-guided thoracic epidural anesthesia.

Group Type ACTIVE_COMPARATOR

Thoracic epidural anesthesia

Intervention Type OTHER

Patients will receive an ultrasound-guided thoracic epidural anesthesia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Subcostal and lateral transversus abdominis plane block

Patients will receive an ultrasound-guided combined subcostal and lateral transversus abdominis plane block.

Intervention Type OTHER

Thoracic epidural anesthesia

Patients will receive an ultrasound-guided thoracic epidural anesthesia.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I-III.
* Scheduled for major abdominal surgeries including: (e.g., gastrectomy, colectomy, hepatectomy, cystectomy, total abdominal hysterectomy, Nephrectomy, pancreatectomy).

Exclusion Criteria

* Intraoperative hemodynamic instability.
* History or evidence of coagulopathy.
* Infection or abdominal wall masses at injection site.
* Morbid obesity.
* Other Medical conditions including mental illness or substance abuse.
* Known allergy to local anesthetics.
* Chronic opioid use or chronic pain conditions.
* Pregnancy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bahaa Gamal Saad Mohamed

Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut University

Asyut, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bahaa G Saad, MD

Role: CONTACT

00201555590977

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bahaa G Saad, MD

Role: primary

00201555590977

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

620

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.